Cetilistat (BioDeep_00000177175)
human metabolite blood metabolite
代谢物信息卡片
化学式: C25H39NO3 (401.29297840000004)
中文名称: 新利司他
谱图信息:
最多检出来源 Homo sapiens(blood) 9.95%
分子结构信息
SMILES: CCCCCCCCCCCCCCCCOC1=NC2=C(C=C(C)C=C2)C(=O)O1
InChI: InChI=1S/C25H39NO3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-19-28-25-26-23-18-17-21(2)20-22(23)24(27)29-25/h17-18,20H,3-16,19H2,1-2H3
描述信息
C471 - Enzyme Inhibitor > C29715 - Gastrointestinal Lipase Inhibitor
D057847 - Lipid Regulating Agents
D019440 - Anti-Obesity Agents
D004791 - Enzyme Inhibitors
同义名列表
数据库引用编号
8 个数据库交叉引用编号
- ChEBI: CHEBI:134721
- PubChem: 9952916
- HMDB: HMDB0249835
- DrugBank: DB06586
- ChEMBL: CHEMBL2103825
- Wikipedia: Cetilistat
- chemspider: 8128526
- CAS: 282526-98-1
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Shuofeng Yuan, Jasper F W Chan, Kenn K H Chik, Chris C Y Chan, Jessica O L Tsang, Ronghui Liang, Jianli Cao, Kaiming Tang, Lin-Lei Chen, Kun Wen, Jian-Piao Cai, Zi-Wei Ye, Gang Lu, Hin Chu, Dong-Yan Jin, Kwok-Yung Yuen. Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system.
Pharmacological research.
2020 09; 159(?):104960. doi:
10.1016/j.phrs.2020.104960. [PMID: 32473310] - Shristy S Tiwari, Sumit Mukesh, Abhay T Sangamwar, M V N Kumar Talluri. In vivo metabolic investigation of cetilistat in normal versus pseudo-germ-free rats using UPLC-QTOFMS/MS and in silico toxicological evaluation of its metabolites.
Biomedical chromatography : BMC.
2020 Aug; 34(8):e4860. doi:
10.1002/bmc.4860. [PMID: 32311767] - Sonia A Tucci, Emma J Boyland, Jason Cg Halford. The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents.
Diabetes, metabolic syndrome and obesity : targets and therapy.
2010 May; 3(?):125-43. doi:
10.2147/dmsott.s7005. [PMID: 21437083] - Andrew Bryson, Stephan de la Motte, Christopher Dunk. Reduction of dietary fat absorption by the novel gastrointestinal lipase inhibitor cetilistat in healthy volunteers.
British journal of clinical pharmacology.
2009 Mar; 67(3):309-15. doi:
10.1111/j.1365-2125.2008.03311.x. [PMID: 19220279] - Y Yamada, T Kato, H Ogino, S Ashina, K Kato. Cetilistat (ATL-962), a novel pancreatic lipase inhibitor, ameliorates body weight gain and improves lipid profiles in rats.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
2008 Aug; 40(8):539-43. doi:
10.1055/s-2008-1076699. [PMID: 18500680]